Jul 12, 2021BioTech IQ | Targeting treatment related toxicities - Michael McCullar Mike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer...
Jul 1, 2021Health Professional Radio I OnQuality Pharmaceuticals – Phase 2 Cancer Supportive Care Therapy ForDr. Michael McCullar, CEO, and Dr. Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company...
Jul 1, 2021Life Science Leader I Coming Out Of Stealth Mode: What To Know And DoBy Wayne Koberstein This article draws on the experience of five company CEOs with various backgrounds and views of stealth transitions....
Jun 4, 2021Clinical Trials Arena I OnQuality: developing treatments to combat cancer therapy side effectsBy Kezia Parkins OnQuality’s chief medical officer and co-founder Hong Tang discusses the firm’s pipeline of cancer supportive care...
May 11, 2021Prognosis Ohio | Relief for Cancer Patients: OSU's Dr. Benjamin Kaffenberger on an Ongoing Derma...On the new Prognosis Ohio, part of the WCBE Podcast Experience, Dan Skinner talks with OSU dermatologist and researcher, Benjamin...
May 4, 2021Empowered Patient I Targeted Cancer Supportive Care Agent for Skin Toxicities with OnQuality By Karen Jagoda Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the...